Structural insights into blood coagulation factor VIII: Procoagulant complexes, membrane binding, and antibody inhibition-Reference-Cited by-同舟云学术

Structural insights into blood coagulation factor VIII: Procoagulant complexes, membrane binding, and antibody inhibition

Published:2022-09 Issue:9 Volume:20 Page:1957-1970
ISSN:1538-7836
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:Journal of Thrombosis and Haemostasis

Author:

Childers Kenneth C.^ORCID,Peters Shaun C.^ORCID,Spiegel Paul Clint^ORCID

Publisher

Elsevier BV

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15793

Reference100 articles.

1. A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The recombinate study group;Bray;Blood,1994

2. Inhibitor development in previously untreated patients with hemophilia A: a prospective long‐term follow‐up comparing plasma‐derived and recombinant products;Kreuz;Semin Thromb Hemost,2002

3. Acquired factor VIII inhibitors;Franchini;Blood,2008

4. A factor VIIIa‐mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A mice;Ostergaard;Blood,2021

5. Factor VIII‐mimetic function of humanized bispecific antibody in hemophilia A;Shima;N Engl J Med,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparation of porous carbon spheres by templated self-assembly for rapid hemostasis;Microporous and Mesoporous Materials;2024-01

2. Cellular stress and coagulation factor production: when more is not necessarily better;Journal of Thrombosis and Haemostasis;2023-12

3. Humanization and functional characterization of enhanced coagulation factor IX variants identified through ancestral sequence reconstruction;Journal of Thrombosis and Haemostasis;2023-11

4. A graph-based machine learning framework identifies critical properties of FVIII that lead to hemophilia A;Frontiers in Bioinformatics;2023-05-10

5. Efanesoctocog Alfa: First Approval;Drugs;2023-04-06